Home/Pipeline/Starstim for Depression

Starstim for Depression

Depression

Phase 1/2Active

Key Facts

Indication

Depression

Phase

Phase 1/2

Status

Active

Company

Neuroelectrics

About Neuroelectrics

Neuroelectrics is a private, Barcelona-based biotech firm pioneering a novel approach to neuromodulation for brain disorders. Its core offering is the Starstim platform, which integrates wearable EEG/tES hardware, cloud-based treatment delivery, and personalized protocols based on computational models. The company is advancing therapeutic programs, notably in refractory focal epilepsy and depression, while also serving the research market with its Enobio EEG systems. Neuroelectrics operates at the intersection of medical devices, digital health, and computational neuroscience, aiming to provide a non-pharmacological treatment option for patients with unmet needs.

View full company profile

Therapeutic Areas

Epilepsy Depression

Other Depression Drugs

Drug	Company	Phase	Status
Undisclosed Programs	johnson-and-johnson-innovative-medicine	Pipeline	Active
Depression Clinical Trials	IMA Clinical Research	Not Applicable (Service)	Active
Depression Study	Sun Valley Research Center	Not Disclosed	Active
eTNS Platform	NeuroSigma	Unknown	Active
ALM003	Almatica Pharma	Phase 3	Active
ALM014	Almatica Pharma	Pivotal BA/BE	Active
NRCT-101SR	Neurocentria	Phase 2b/3	Active
Depression Biomarkers	Paradise Genomics	Discovery	Active
Home-tDCS Depression Trial	Soterix Medical	N/A (Device-enabled trial)	Active
BPL-003	AtaiBeckley	Phase 2	Active
VLS-01	AtaiBeckley	Phase 2	Active
NC-2800	Nippon Chemiphar	Phase 2a	Active - Patient enrollment started as of Jan 2026